Physician profile
Michael Berte
NPI 1013985316
$12,464.75
in general payments reported to CMS, 2019-2025
54 companies · $911 in 2025
The $911 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,828 · 2020: $1,007 · 2021: $1,923 · 2022: $2,166 · 2023: $3,533 · 2024: $1,096 · 2025: $911.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,592 · Travel and Lodging: $819 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,591.91 |
| Travel and Lodging | $819.26 |
| Education | $128.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,470.29 | 2019-2023 | Aquabeam Robotic System |
| Astellas Pharma US INC | $1,209.71 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Antares Pharma, INC. | $742.41 | 2019-2024 | Xyosted, Tlando, Nocdurna |
| Blue Earth Diagnostics | $677.82 | 2019-2025 | Posluma |
| Dendreon Pharmaceuticals LLC | $584.79 | 2019-2025 | Provenge |
| Neotract INC. | $568.45 | 2019-2020 | |
| Janssen Biotech, INC. | $564.26 | 2019-2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $544.13 | 2019-2025 | |
| Progenics Pharmaceuticals, INC. | $515.49 | 2021-2025 | Pylarify |
| Coloplast Corp | $397.93 | 2019-2022 | |
| Urovant Sciences INC | $358.00 | 2021-2022 | |
| Abbvie INC. | $324.40 | 2019-2024 | Botox |
| Sumitomo Pharma America, INC. | $319.32 | 2023-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $308.16 | 2021 | |
| Tolmar, INC. | $307.22 | 2023-2025 | Eligard, Jatenzo, Rubraca |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C. R. Bard, INC. & Subsidiaries | $281.40 | 2022-2023 | Bard Urinary Drainage Bag |
| Genzyme Corporation | $281.38 | 2020-2023 | |
| Convatec INC. | $271.60 | 2021-2025 | |
| Tolmar Pharmaceuticals, INC. | $253.26 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $220.22 | 2023-2024 | Prolaris |
| Immunitybio, INC. | $198.70 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $182.43 | 2022 | |
| Amgen INC. | $166.61 | 2019-2022 | |
| Rochester Medical Corporation | $139.85 | 2019-2022 | |
| Pfizer INC. | $128.83 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $113.55 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $106.20 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $94.69 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $94.05 | 2020-2024 | Yonsa |
| Dentsply Ih Ab | $87.71 | 2023-2024 | Lofric, Lofric |
| Myovant Sciences INC. | $86.54 | 2021-2022 | |
| Urogen Pharma, INC. | $85.18 | 2021-2025 | Jelmyto |
| Boston Scientific Corporation | $76.36 | 2019-2025 | Ams 700, Spaceoar Vue System - 10ml |
| Clarus Therapeutics INC. | $72.74 | 2021 | |
| Tempus Ai, INC | $70.48 | 2024-2025 | Xt Cdx |
| Verity Pharmaceuticals INC. | $68.64 | 2022-2025 | Trelstar |
| Zyla Life Sciences, INC. | $62.18 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $51.36 | 2022 | |
| Axonics, INC. | $43.99 | 2020-2023 | Bulkamid, Axonics |
| Dentsply Ih INC. | $42.70 | 2021-2022 | |
| Medtronic, INC. | $40.93 | 2024 | Interstim |
| Allergan, INC. | $33.65 | 2019-2021 | |
| Acerus Pharmaceuticals Corporation | $29.52 | 2020-2021 | |
| Calyxo, INC. | $29.47 | 2024-2025 | Cvac Aspiration System |
| Olympus America INC. | $25.31 | 2022-2024 | Itind System |
| Gilead Sciences, INC. | $18.67 | 2025 | Trodelvy |
| Pharmaand Gmbh | $18.09 | 2025 | Rubraca |
| Accord Healthcare, INC. | $16.40 | 2023 | |
| Laborie Medical Technologies Corp. | $14.88 | 2023 | |
| Halozyme INC | $13.43 | 2023 | |
| Foundation Medicine, INC. | $13.23 | 2023 | |
| Photocure INC | $13.16 | 2023 | Cysview |
| Metuchen Pharmaceuticals | $12.68 | 2019 | |
| Clovis Oncology, INC. | $12.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Berte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.